•
Mar 31, 2023

iRhythm Q1 2023 Earnings Report

Reported financial results for the three months ended March 31, 2023.

Key Takeaways

iRhythm Technologies reported a 20.6% increase in revenue to $111.4 million for the first quarter of 2023, driven by Zio XT and AT volume growth. The gross margin improved to 67.9%, and the company updated its fiscal year 2023 revenue guidance to a range of $480 million to $490 million.

Revenue increased by 20.6% to $111.4 million compared to the first quarter of 2022.

Gross margin improved by 100 basis points to 67.9% compared to the first quarter of 2022.

Cash, cash equivalents, and short-term investments totaled $176.3 million as of March 31, 2023.

Fiscal year 2023 revenue guidance updated to a range of approximately $480 million to $490 million.

Total Revenue
$111M
Previous year: $92.4M
+20.6%
EPS
-$1.29
Previous year: -$0.8
+61.2%
Gross Margin
67.9%
Previous year: 66.9%
+1.5%
Gross Profit
$75.7M
Previous year: $61.8M
+22.5%
Cash and Equivalents
$52.8M
Previous year: $94.8M
-44.3%
Total Assets
$422M
Previous year: $429M
-1.6%

iRhythm

iRhythm

Forward Guidance

iRhythm projects revenue for the full year 2023 to grow approximately 17% to 19% compared to prior year results, ranging from $480 million to $490 million. Gross margin for the full year 2023 is expected to range from 69% to 70% and adjusted operating expenses are expected to range between $417 and $427 million. Adjusted EBITDA margin for the full year 2023 is expected to range from approximately negative 0.5% to 0.5% of revenues.